Effective drug policy: A new approach demonstrated in the Drug Policy Modelling Program

Drug and Alcohol Review

Volumn 26, Issue 3, 2007, Pages 265-271

  Ritter, Alison ^a   Bammer, Gabriele ^b   Hamilton, Margaret ^c   Mazerolle, Lorraine ^d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b The Australian National University   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d GRIFFITH UNIVERSITY   (Australia)

Author keywords

Drug policy; Integration; Multi disciplinary

Indexed keywords

STREET DRUG;

ADDICTION; ARTICLE; AUSTRALIA; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; DRUG CONTROL; ECONOMICS; EVIDENCE BASED MEDICINE; HUMAN; LEGAL ASPECT; MANAGEMENT; POLICY; POLITICS;

AUSTRALIA; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DRUG AND NARCOTIC CONTROL; EVIDENCE-BASED MEDICINE; HUMANS; POLICY MAKING; POLITICS; PUBLIC POLICY; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 34147117907     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230701247665     Document Type: Article

References (54)

1. Collins DJ, Lapsley HM. Counting the cost: estimates of the social costs of drug abuse in 1998-1999. Canberra: Commonwealth of Australia; 2002.
2. Anderson LM, Brownson RC, Fullilove MT, Teutsch SM, Novick LF, Fielding J, et al. Evidence-based public health policy and practice: promises and limits. Am J Prevent Med 2005;28(5 Suppl. 1):226-30.
3. Weiss CH, Murphy-Graham E, Birkeland S. An alternate route to policy influence: how evaluations affect D.A.R.E. Am J Eval 2005;26:12-30.
4. Lin V, Gibson B, eds. Evidence-based health policy. Problems and possibilities. Oxford: Oxford University Press; 2003.
5. Ritter A, McDonald D. Monograph No. 02: Drug policy interventions: a comprehensive list and a review of classification schemes. DPMP Monograph Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.
6. Winkler D, Caulkins JP, Behrens DA, Tragler G. Estimating the relative efficiency of various forms of prevention at different stages of a drug epidemic. Socio-Econ Plan Sci 2004;38:43-56.
7. Everingham SS, Rydell CP. Modeling the demand for cocaine. Santa Monica: RAND Corporation; 1994.
8. Lindblom CE. The science of 'muddling through'. Public Admin Rev 1959;19:79-88.
9. Gregrich RJ. A note to researchers: communicating science to policy makers and practitioners. J Subst Abuse Treat 2003;25:233-7.
10. Secker A. The policy-research interface: an insider's view. Addiction 1993;88(Suppl.):115S-120S.
11. Bammer G. Integration and implementation sciences: building a new specialization. Ecol Society 2005;10(2):6 (online URL: http://www. ecologyandsociety.org/vol10/iss2/art6/).
12. Bammer G. A new science for integration and implementation. In: Perez P, Batten D, eds. Complex science for a complex world-exploring human ecosystems with agents. Canberra: ANU Press; 2006:95-107.
13. Bammer G, Deane P. Bulletin No. 17: Integration in DPMP: an organising principle and an expanded set of tools. DPMP Bulletin Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.
14. Mazerolle L, Soole D, Rombouts S. Drug law enforcement: A review of the evaluation literature. Police Quart (in press).
15. Ritter A, Cameron J. Monograph No. 06: A systematic review of harm reduction. DPMP Monograph Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.
16. Soole DW, Mazerolle L, Rombouts, S. Monograph No. 07: School based drug prevention: a systematic review of the effectiveness on illicit drug use. DPMP Monograph Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.
17. Mazerolle L, Soole D, Rombouts S. Street-level drug law enforcement: a meta-analytic review. J Exp Criminol 2006;2:409-35.
18. Choi BCK, Pang T, Lin V, Puska P, Sherman G, Goddard M, et al. Can scientists and policy makers work together? J Epidemiol Comm Health 2005;59:632-7.
19. Crosswaite C, Curtice L. Disseminating research results - the challenge of bridging the gap between health research and heath action. Health Promot Int 1994;9:289-96.
20. Gibson B. Beyond 'two communities'. In: Lin V, Gibson B, eds. Evidence-based health policy. Problems and possibilities. Oxford: Oxford University Press; 2003.
21. Lin V. Competing rationalities: evidence-based health policy? In: Lin V, Gibson B, eds. Evidence-based health policy. Problems and possibilities. Oxford: Oxford University Press; 2003:3-17.
22. Colebatch HK. Policy 2nd ed. Philadelphia: Open University Press; 2002.
23. McDonald D, Bammer G, Breen G. Monograph No. 04: Australian illicit drugs policy: mapping structures and processes. DPMP Monograph Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.
24. Lewis JM. Being around and knowing the players: networks of influence in health policy. Soc Sci Med 2006;62:2125-36.
25. Midgley G. Systemic intervention: philosophy, methodology and practice. New York: Plenum/Kluwer; 2000.
26. Midgley G, Winstanley A, Gregory W, Foote J. Monograph No. 13: Scoping the potential uses of systems thinking in developing policy on illicit drugs. DPMP Monograph Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.
27. Midgley G, Winstanley A, Gregory W, Foote J. Bulletin No. 11: Scoping the potential uses of systems thinking in developing policy on illicit drugs. DPMP Bulletin Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.
28. Hough L. A meeting of the minds. What happens when the Kennedy School's executive sessions unite practitioners and academics together? Harvard University John F Kennedy School of Government Bulletin (http://www.ksg.harvard. edu/ksgpress/bulletin/spring2002/features/meeting.html);Spring 2002:32-37.
29. Moore MH, Hartmann FX. On the theory and practice of 'Executive Sessions': Unpublished; 1999.
30. Bammer G. Bulletin No. 4: Exploring executive sessions to generate effective new approaches to illicit drugs. DPMP Bulletin Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.
31. Vos T, Haby M, Magnus A, Mihalopoulos C, Andrews G, Carter R. Assessing the cost-effectiveness in mental health: helping policy-makers prioritize and plan health services. Aus NZ J Psychiatry 2005;39:701-12.
32. Moore T, Ritter A, Caulkins J. Bulletin No. 12: Economic modelling: cost-effectiveness of three policy options. DPMP Bulletin Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.
33. Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, et al. Twelve month outcomes of treatment for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Sydney, New South Wales: National Drug and Alcohol Research Centre, University of New South Wales; 2003.
34. Caulkins J, Dietze P, Ritter A. Dynamic compartmental model of trends in Australia drug use. Health Care Manag Sci (in press).
35. Moore TJ. Monograph No. 01: What is Australia's 'drug budget'? The policy mix of illicit drug-related government spending in Australia. DPMP Monograph Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.
36. Moore TJ, Caulkins JP, Ritter A, Dietze P, Monagle S, Pruden J. Monograph No. 09: Heroin markets in Australia: current understandings and future possibilities. DPMP Monograph Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.
37. Caulkins J, Reuter P. What price data tells us about drug markets. J Drug Iss 1998;28:593-613.
38. Godkin C, Caulkins J, Dietze P. Bulletin No. 9: Examination of heroin and amphetamine purity in Victoria. DPMP Bulletin Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.
39. Moore T, Caulkins J, Dietze P. Bulletin No. 8: Illicit drugs in Australia: what do we know about the role of price? DPMP Bulletin Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.
40. Moore T. Bulletin No. 10: The impact of heroin seizures (economic back of the envelope calculations). DPMP Bulletin Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.
41. Rescher N. Complexity: a philosophical overview. New Brunswick, New Jersey: Transaction Publishers; 1998.
42. Holland JH. Hidden order: how adaptation builds complexity. Reading, Mass.: Addison-Wesley; 1995.
43. Perez P, Dray A, Ritter A, Dietze P, Moore T, Mazerolle L. SimDrug: exploring the complexity of illicit drug markets. In: Perez P, Batten D, eds. Complex science for a complex world-exploring human ecosystems with agents. Canberra: ANU Press; 2006:193-224.
44. Perez P, Dray A. Monograph No. 11: SimDrug: exploring the complexity of heroin use in Melbourne. DPMP Monograph Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.
45. Agar M. Agents in living color: towards emic agent-based models. J Artific Soc Soc Sim 2005;8(1):http://jasss.soc.surrey.ac.uk/8/1/4.html.
46. Agar M, Wilson D. DrugMart: heroin epidemics as complex adaptive systems. Complexity 2002;7:44-52.
47. Caulkins JP, Behrens DA, Knoll C, Tragler G, Zuba D. Modeling dynamic trajectories of initiation and demand: the case of the US cocaine epidemic. Health Care Manage Sci 2004;7:319-29.
48. Levy DT, Chaloupka F, Gitchell J, Mendez D, Warner KE. The use of simulation models for the surveillance, justification, and understanding of tobacco control policies. Health Care Manage Sci 2002;5:113-20.
49. Rossi C. A mover-stayer type model for epidemics of problematic drug use. Bull Narcot 2001;53:39-64.
50. Tengs TO, Ahmad S, Moore R, Gage E. Federal policy mandating safer cigarettes: a hypothetical simulation of the anticipated population health gains or losses. J Pol Anal Manage 2004;23:857-72.
51. Godfrey C, Stewart D, Gossop M. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS). Addiction 2004;99:697-707.
52. Smithson M. Ignorance and uncertainty: emerging paradigms. New York: Springer-Verlag; 1989.
53. Gorman DM, Gruenewald PJ, Hanlon PJ, Mezic I, Waller LA, Castillo-Chavez C, et al. Implications of systems dynamic models and control theory for environmental approaches to the prevention of alcohol and other drug use-related problems. Subst Use Misuse 2004;39:1713-50.
54. Giacomini M. Interdisciplinarity in health services research: dreams and nightmares, maladies and remedies. J Health Serv Res Pol 2004;9:177-84.